Pharmacokinetic advantage of an intranasal preparation of a novel anti-osteoporosis drug, L-Asp-hexapeptide-conjugated estradiol.

Source:http://linkedlifedata.com/resource/pubmed/id/16755022

Download in:

View as

General Info

PMID
16755022